Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000883287 | SCV001026582 | likely benign | Methylmalonic aciduria, cblB type | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000883287 | SCV003808847 | uncertain significance | Methylmalonic aciduria, cblB type | 2022-04-15 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000883287 | SCV001459542 | benign | Methylmalonic aciduria, cblB type | 2020-04-10 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003910420 | SCV004719651 | likely benign | MMAB-related disorder | 2022-07-12 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |